Avocet Polymer Technologies, Inc. is a well-established pharmaceutical company that is dedicated to providing safe and effective therapies for inflamed, painful, and hypertrophic scars. Avocet was founded in 1996 and has been producing leading products that are based on known pharmacology and drug delivery technology. Headquartered in Chicago, Illinois, the company designs, manufacturers, develops and markets drugs, ointments and devices for the treatment of scar conditions.
Avocet distinguishes itself from other scar product development companies through its rational design of scar treatment and prevention therapies. Avocet currently has two products on the market, Avogel and Avosil, which are widely used by patients around the world for control of healing burn and trauma scars during the first year after injury. Avocet is committed to bringing these effective and affordable products into a greater number of hospitals, pharmacies, and homes across the country.
Avocet has more than 30 patents and has several new scar prevention and reduction products under development. Avocet's technology helps prevent scarring of the skin and of internal organs.